Rolitrans is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Based on research, the following side effects have been observed when Rolitrans is used -
Moderate
Mild
Is the use of Rolitrans safe for pregnant women?
Rolitrans can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Rolitrans right away. Take your doctor's advice before taking it again.
Is the use of Rolitrans safe during breastfeeding?
Rolitrans can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Rolitrans on the Kidneys?
Rolitrans can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Rolitrans on the Liver?
The liver can be affected by Rolitrans . If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Rolitrans only after medical advice.
What is the effect of Rolitrans on the Heart?
Effects of Rolitrans on heart can be severe. It is not safe to use without doctor's advice.
Rolitrans should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rolitrans unless your doctor advises you to do so -
Is this Rolitrans habit forming or addictive?
Rolitrans is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Rolitrans as it does not make you drowsy.
Is it safe?
Yes, but consume Rolitrans only on doctor's advice.
Is it able to treat mental disorders?
Rolitrans is unable to treat or cure mental disorders.
Interaction between Food and Rolitrans
There isn't any research available on the side effects of taking Rolitrans with food.
Interaction between Alcohol and Rolitrans
Taking alcohol with Rolitrans can be dangerous.
No, you cannot take the Rolitrans with fluconazole, as it may change the effect of the Rolitrans and cause some serious side effects, always consult your doctor before taking this drug combination.
Yes, you can discontinue the Rolitrans once you get the relief from burns. You are recommended to consult a doctor before discontinuing this medicine.
Rolitrans injection is given by your doctor or nurse. Do not take it by own. Rolitrans tablets or capsules are taken with or without food or as advised/prescribed by your doctor. The topical dosage form of Rolitrans is applied 2 times a day and should be applied at the same time everyday, Do not apply more or less than the prescribed by the doctor.
Yes, Rolitrans may cause diarrhea. It has been reported by the patients who are taking this drug. If you are experiencing the same after taking this drug, you are advised to consult about it with your doctor.
Yes, Rolitrans is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as headache, diarrhea, constipation, nausea, vomiting. If you experience any discomfort after taking this do inform your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prograf® (tacrolimus)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 881
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1165-1167